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Hormonal Contraceptives
• Contain estrogen and/or progestin, two female 
sex hormones that are used to prevent 
ovulation                                                                      
(American Society of Health-System Pharmacists, 2020) 
• The Centers for Disease Control and 
Prevention (CDC) reported that between 2015 
and 2017, 64.9% of the 72 million women aged 
15-49 in the U.S. were using contraception, 
and 22.9% of those were hormonal in nature. 
(Daniels & Abma, 2018)
• The use of birth control has been associated 
with increased risk of breast cancer.            
(Dorchak et al., 2018; Morch et al., 2017)
• Morch et al., found that risk of breast cancer 
among all current or recent (discontinuation 
within previous six months) users of  hormonal 
contraception was higher than among women 
who had never used them, and the risk 
increased with longer duration of use. (See 
table below.)
Table 1: Relative Risk of Breast Cancer According to 
Time since Use and Duration of Use of Any Type of 
Hormonal Contraception (Morch et al., 2017)
Breast Density Factors
• Breast density has a significant inverse 
association with the age at which women start 
using hormonal contraceptives, and a positive 
association with the duration of contraceptive 
hormone use.                                              
(Dorgan et al., 2013)
• Increased breast density is directly related to 
the risk of breast cancer.                         
(Houssami, 2016)
• Increased tumor size and worsened prognosis 
are associated with increased breast density.
(Rafferty et al., 2016)
Using DBT to Screen             
Dense Breasts
• In 2016, Houssami noted that DBT “could 
provide a much more sensitive screening 
mammogram in women with dense breasts”
(p. 516).
• The same year, a large study by Rafferty et al. 
(2016) comparing over 270,000 2D digital 
mammograms to more than 170,000 DBT 
exams reported “an increase in cancer 
detection of 1.6 per 1000 in women with 
heterogeneously dense breasts, but no 
improvement in cancer detection with 
extremely dense breasts.” (DenseBreast Info, 2020)
• Results of another large more recent study of 
DBT compared with 2D digital mammography 
revealed an increase in cancer detection of 
more than 2.5 per 1000 women aged 40-49 
with dense breasts                    (Conant et al., 2019)
• DBT was also shown to be associated with 
decreased false-positive test results and 
increased breast cancer detection in the 
Conant et al. (2019) study. 
Case Study #1
Figure 2: Digital MLO Projections of Breasts
• Female, 32 years of age, palpable mass in the 
upper outer quadrant of the right breast:
• On hormonal contraception 
• Scattered fibroglandular density
• Maternal history of breast cancer
• 2-D mammogram confirmed asymmetry and 
architectural distortion
• Classified as BIRADS-5
• 3-D mammogram showed more detail: 
Spiculated density with 3.2 cm. x 2.8 cm. 
measurements
• Final Diagnosis: Ductal hyperplasia, fibrocystic 
changes, metaplasia and adenosis. No 
malignancy            (Barkhausen, Rody, & Schaefer, 2015)
Case Study #2
Figure 3: Digital MLO Projections of Breasts
• Female, 48 years of age:
• Took hormonal contraceptives until age 42
• Homogeneously dense breasts
• No family history of breast cancer
• 2D mammogram showed a microcalcification
cluster in the medial half of the left breast
• Classified as BIRADS 4
• 3D mammogram of the left breast showed 
architectural distortion and multiple clusters of 
microcalcifications 9 cm. away from the nipple
• Final diagnosis: Fibrocystic changes with no 
evidence of malignancy                            
(Barkhausen et al., 2015)
Table 2: BI-RADS Scoring (Zubia & Ramirez-Arambula, 2017)
Conclusion
• Breast density can increase with duration of 
contraceptive hormone use.
• The risk of developing breast cancer can also 
increase with contraceptive hormone use.
• An increase in breast density is directly related 
to the risk of breast cancer.
• Using 3-D mammography provides more 
detailed imaging than 2-D and is more effective 
in evaluating dense breast tissue. 
• DBT is optimal for women with dense breasts 
and those using hormonal contraceptives.
Introduction to Digital Breast 
Tomosynthesis (DBT)
• It is also known as 3D mammography.
• Similar to 2D digital mammographic imaging, 
DBT uses x-rays to acquire digital images of 
the breast.
• However, unlike 2D digital mammography, DBT 
is able to scan through the many layers of 
dense breast tissues.
• Images are obtained by the x-ray tube moving 
in an arc around a compressed breast on a 
stationary detector, while delivering a 
continuous beam.
• Images are then reconstructed into thin layers 
that can be viewed individually or scrolled 
through to reduce overlap of tissues.          
(Dense Breast Info, 2020)
Figure 1: 2D vs 3D screenings (Dense Breast Info, 2020)
• Dense breast tissue appears white on 
mammograms.
• Using 2D instead of 3D mammography on 
dense breasts can obscure pathology because 
breasts structures can overlap each another.
• Overlapping tissues on 2D mammography can 
also make normal tissue appear abnormal. 
(Aragon, 2017)
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